FDA Clearance Tracker · P850020-S013
PROSORBA COLUMN
Last checked: Nov 20, 2026Latest source record: Oct 26, 2001 (this decision)Source: openFDAMethods & limitations
Decided
Oct 26, 2001
Approved
Time to decision
179 days
Received Apr 30, 2001. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Unclassified
The decision
- FDA number
- P850020-S013
- Device name
- PROSORBA COLUMN
- Applicant
- Fresenius Hemocare, Inc.
- Applicant location
- Waltham, MA
- Received
- Apr 30, 2001
- Decided
- Oct 26, 2001
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P850020
Device type
- Device class
- Unclassified
- Specialty
- GI, Urology & Nephrology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR REVISED LABELING THAT RELATES NEW POST-MARKET SAFETY INFORMATION REGARDING EPISODES OF VASCULITIS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH THE PROSORBA(R) COLUMN.
Source documents
Other decisions for Fresenius Hemocare, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.